Key Financial Figures

Consolidated Financial Results for FY2026:

  • Revenue: ₹7,728 million
  • Profit After Tax: ₹1,014 million (31% growth year-on-year)
  • Includes fair valuation gain of investment in Apulki Healthcare Private Limited: ₹221.75 million
  • Diluted EPS: ₹30.88 (31% improvement over prior year)
  • Operating cash flow: ₹1,431 million (64% improvement from ₹873 million in FY2025)

Dividend Declaration

  • Board recommended final dividend of ₹2 per share
  • Face value of shares: ₹5

Strategic and Operational Highlights

Management Commentary from Yash Mutha, Managing Director:

  • FY2026 described as "year of deliberate and disciplined investment" into long-term architecture
  • PAT of ₹1,014 million represents highest reported PAT in company's history since listing
  • Strong operating cash flow improvement demonstrates structural improvement in collections framework and working capital management
  • Growth roadmap anchored in long-term PPP contracts, scaling B2C vertical, and entry into tertiary care through Apulki Healthcare

Management Commentary from Mitesh Dave, Group CEO:

  • Retail diagnostics vertical (Krsnaa Retail Private Limited) achieved 8 times revenue growth in twelve months
  • Retail touchpoints increased 7 times to 3,500 locations across 5 states
  • Retail vertical established as "structurally important and independently scalable growth engine"
  • Focus for FY2027 remains on disciplined execution, transparency, and strong governance standards